SS Innovations International, Inc.
SS Innovations International, Inc. SSII Peers
See (SSII) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SSII | $8.91 | -0.67% | 1.73B | -111.37 | -$0.08 | N/A |
| SEMHF | $55.30 | +0.04% | 62.02B | 26.59 | $2.08 | +2.03% |
| SMMNY | $27.46 | -0.76% | 61.60B | 26.40 | $1.04 | +1.22% |
| RYLPF | $24.21 | -4.86% | 22.40B | 83.49 | $0.29 | +3.89% |
| SONVF | $338.73 | -0.65% | 20.19B | 31.33 | $10.81 | +1.72% |
| SONVY | $66.85 | -1.41% | 19.92B | 30.95 | $2.16 | +1.42% |
| SNNUF | $14.21 | -0.63% | 12.43B | 30.23 | $0.47 | +2.64% |
| CHEOF | $175.40 | +3.18% | 11.44B | 48.59 | $3.61 | +1.58% |
| CHEOY | $86.72 | -2.19% | 11.34B | 47.91 | $1.81 | +1.61% |
| WILYY | $20.20 | +4.94% | 8.94B | 20.20 | $1.00 | N/A |
Stock Comparison
SSII vs SEMHF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SEMHF has a market cap of 62.02B. Regarding current trading prices, SSII is priced at $8.91, while SEMHF trades at $55.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SEMHF's P/E ratio is 26.59. In terms of profitability, SSII's ROE is -1.33%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, SSII is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SMMNY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SMMNY has a market cap of 61.60B. Regarding current trading prices, SSII is priced at $8.91, while SMMNY trades at $27.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SMMNY's P/E ratio is 26.40. In terms of profitability, SSII's ROE is -1.33%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, SSII is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs RYLPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, RYLPF has a market cap of 22.40B. Regarding current trading prices, SSII is priced at $8.91, while RYLPF trades at $24.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas RYLPF's P/E ratio is 83.49. In terms of profitability, SSII's ROE is -1.33%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, SSII is more volatile compared to RYLPF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SONVF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SONVF has a market cap of 20.19B. Regarding current trading prices, SSII is priced at $8.91, while SONVF trades at $338.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SONVF's P/E ratio is 31.33. In terms of profitability, SSII's ROE is -1.33%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, SSII is more volatile compared to SONVF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SONVY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SONVY has a market cap of 19.92B. Regarding current trading prices, SSII is priced at $8.91, while SONVY trades at $66.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SONVY's P/E ratio is 30.95. In terms of profitability, SSII's ROE is -1.33%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, SSII is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SNNUF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SNNUF has a market cap of 12.43B. Regarding current trading prices, SSII is priced at $8.91, while SNNUF trades at $14.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SNNUF's P/E ratio is 30.23. In terms of profitability, SSII's ROE is -1.33%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, SSII is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs CHEOF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CHEOF has a market cap of 11.44B. Regarding current trading prices, SSII is priced at $8.91, while CHEOF trades at $175.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CHEOF's P/E ratio is 48.59. In terms of profitability, SSII's ROE is -1.33%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, SSII is more volatile compared to CHEOF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs CHEOY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CHEOY has a market cap of 11.34B. Regarding current trading prices, SSII is priced at $8.91, while CHEOY trades at $86.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CHEOY's P/E ratio is 47.91. In terms of profitability, SSII's ROE is -1.33%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, SSII is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs WILYY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, WILYY has a market cap of 8.94B. Regarding current trading prices, SSII is priced at $8.91, while WILYY trades at $20.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas WILYY's P/E ratio is 20.20. In terms of profitability, SSII's ROE is -1.33%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, SSII is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs WILLF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, WILLF has a market cap of 7.86B. Regarding current trading prices, SSII is priced at $8.91, while WILLF trades at $38.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas WILLF's P/E ratio is 19.11. In terms of profitability, SSII's ROE is -1.33%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, SSII is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs GNGBY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, GNGBY has a market cap of 5.51B. Regarding current trading prices, SSII is priced at $8.91, while GNGBY trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas GNGBY's P/E ratio is 35.96. In terms of profitability, SSII's ROE is -1.33%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, SSII is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs GNGBF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, SSII is priced at $8.91, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, SSII's ROE is -1.33%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, SSII is more volatile compared to GNGBF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs AMBBY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, AMBBY has a market cap of 4.18B. Regarding current trading prices, SSII is priced at $8.91, while AMBBY trades at $15.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas AMBBY's P/E ratio is 75.05. In terms of profitability, SSII's ROE is -1.33%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, SSII is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs NHNKY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, NHNKY has a market cap of 4.06B. Regarding current trading prices, SSII is priced at $8.91, while NHNKY trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas NHNKY's P/E ratio is 21.24. In terms of profitability, SSII's ROE is -1.33%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, SSII is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs AMBFF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, AMBFF has a market cap of 4.02B. Regarding current trading prices, SSII is priced at $8.91, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, SSII's ROE is -1.33%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, SSII is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs NHNKF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, NHNKF has a market cap of 2.46B. Regarding current trading prices, SSII is priced at $8.91, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, SSII's ROE is -1.33%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, SSII is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs VTRLY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, SSII is priced at $8.91, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, SSII's ROE is -1.33%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, SSII is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs STSEY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, SSII is priced at $8.91, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas STSEY's P/E ratio is 39.41. In terms of profitability, SSII's ROE is -1.33%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, SSII is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs GNNDY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, GNNDY has a market cap of 2.02B. Regarding current trading prices, SSII is priced at $8.91, while GNNDY trades at $41.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas GNNDY's P/E ratio is 16.74. In terms of profitability, SSII's ROE is -1.33%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, SSII is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs GGNDF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, SSII is priced at $8.91, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas GGNDF's P/E ratio is 15.66. In terms of profitability, SSII's ROE is -1.33%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, SSII is more volatile compared to GGNDF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs OSSFF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, SSII is priced at $8.91, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, SSII's ROE is -1.33%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, SSII is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs DWRKF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, SSII is priced at $8.91, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, SSII's ROE is -1.33%, compared to DWRKF's ROE of N/A. Regarding short-term risk, SSII is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs MCRPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, SSII is priced at $8.91, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, SSII's ROE is -1.33%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, SSII is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs OSSUY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, SSII is priced at $8.91, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, SSII's ROE is -1.33%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, SSII is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs MEDGF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, SSII is priced at $8.91, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, SSII's ROE is -1.33%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, SSII is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs DRWKF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DRWKF has a market cap of 1.23B. Regarding current trading prices, SSII is priced at $8.91, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DRWKF's P/E ratio is 9.10. In terms of profitability, SSII's ROE is -1.33%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, SSII is more volatile compared to DRWKF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs DGWPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DGWPF has a market cap of 1.19B. Regarding current trading prices, SSII is priced at $8.91, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DGWPF's P/E ratio is 7.71. In terms of profitability, SSII's ROE is -1.33%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, SSII is more volatile compared to DGWPF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs XVIPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, SSII is priced at $8.91, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas XVIPF's P/E ratio is 74.77. In terms of profitability, SSII's ROE is -1.33%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, SSII is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs LFTSF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, SSII is priced at $8.91, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, SSII's ROE is -1.33%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, SSII is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs ELEAF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, SSII is priced at $8.91, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ELEAF's P/E ratio is 12.22. In terms of profitability, SSII's ROE is -1.33%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, SSII is more volatile compared to ELEAF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs MDRSF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, SSII is priced at $8.91, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, SSII's ROE is -1.33%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, SSII is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs CALZF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CALZF has a market cap of 615.54M. Regarding current trading prices, SSII is priced at $8.91, while CALZF trades at $0.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CALZF's P/E ratio is 89.10. In terms of profitability, SSII's ROE is -1.33%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, SSII is more volatile compared to CALZF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs AVMR Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, SSII is priced at $8.91, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas AVMR's P/E ratio is -18.34. In terms of profitability, SSII's ROE is -1.33%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, SSII is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs CLVSF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, SSII is priced at $8.91, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, SSII's ROE is -1.33%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, SSII is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs IOBCF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, IOBCF has a market cap of 388.16M. Regarding current trading prices, SSII is priced at $8.91, while IOBCF trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas IOBCF's P/E ratio is 37.86. In terms of profitability, SSII's ROE is -1.33%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, SSII is less volatile compared to IOBCF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs HYBT Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, SSII is priced at $8.91, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas HYBT's P/E ratio is N/A. In terms of profitability, SSII's ROE is -1.33%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, SSII is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs EAPIF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, SSII is priced at $8.91, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas EAPIF's P/E ratio is -1.98. In terms of profitability, SSII's ROE is -1.33%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, SSII is more volatile compared to EAPIF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SNWV Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SNWV has a market cap of 266.94M. Regarding current trading prices, SSII is priced at $8.91, while SNWV trades at $31.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SNWV's P/E ratio is -5.01. In terms of profitability, SSII's ROE is -1.33%, compared to SNWV's ROE of +1.00%. Regarding short-term risk, SSII is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs CSSPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, SSII is priced at $8.91, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, SSII's ROE is -1.33%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, SSII is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs CYBQY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CYBQY has a market cap of 254.83M. Regarding current trading prices, SSII is priced at $8.91, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CYBQY's P/E ratio is -61.00. In terms of profitability, SSII's ROE is -1.33%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, SSII is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs CLLKF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CLLKF has a market cap of 253.16M. Regarding current trading prices, SSII is priced at $8.91, while CLLKF trades at $3.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CLLKF's P/E ratio is -8.14. In terms of profitability, SSII's ROE is -1.33%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, SSII is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs HTLZF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, SSII is priced at $8.91, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, SSII's ROE is -1.33%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, SSII is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs BCCOY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, BCCOY has a market cap of 221.04M. Regarding current trading prices, SSII is priced at $8.91, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, SSII's ROE is -1.33%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, SSII is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs IMPZY Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, SSII is priced at $8.91, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, SSII's ROE is -1.33%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, SSII is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs AVHHL Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, AVHHL has a market cap of 176.38M. Regarding current trading prices, SSII is priced at $8.91, while AVHHL trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas AVHHL's P/E ratio is -3.23. In terms of profitability, SSII's ROE is -1.33%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, SSII is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs CYBQF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, SSII is priced at $8.91, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CYBQF's P/E ratio is -65.00. In terms of profitability, SSII's ROE is -1.33%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, SSII is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs BRNHF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, SSII is priced at $8.91, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, SSII's ROE is -1.33%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, SSII is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs EKDHF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, EKDHF has a market cap of 161.81M. Regarding current trading prices, SSII is priced at $8.91, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, SSII's ROE is -1.33%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, SSII is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs JMDMF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, JMDMF has a market cap of 151.31M. Regarding current trading prices, SSII is priced at $8.91, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, SSII's ROE is -1.33%, compared to JMDMF's ROE of N/A. Regarding short-term risk, SSII is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs PXMBF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, PXMBF has a market cap of 142.82M. Regarding current trading prices, SSII is priced at $8.91, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, SSII's ROE is -1.33%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, SSII is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs BRSYF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, SSII is priced at $8.91, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, SSII's ROE is -1.33%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, SSII is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs AMEUF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, SSII is priced at $8.91, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, SSII's ROE is -1.33%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, SSII is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs VMTHF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, SSII is priced at $8.91, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, SSII's ROE is -1.33%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, SSII is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs FDMDF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, SSII is priced at $8.91, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, SSII's ROE is -1.33%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, SSII is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs RSHUF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, SSII is priced at $8.91, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, SSII's ROE is -1.33%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, SSII is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs CKMTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, SSII is priced at $8.91, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, SSII's ROE is -1.33%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, SSII is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs SOMNF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, SSII is priced at $8.91, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, SSII's ROE is -1.33%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, SSII is more volatile compared to SOMNF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs DMTRF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, SSII is priced at $8.91, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, SSII's ROE is -1.33%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, SSII is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs SNZZF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, SSII is priced at $8.91, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, SSII's ROE is -1.33%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, SSII is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs RDGL Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, RDGL has a market cap of 50.79M. Regarding current trading prices, SSII is priced at $8.91, while RDGL trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas RDGL's P/E ratio is -11.20. In terms of profitability, SSII's ROE is -1.33%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, SSII is more volatile compared to RDGL. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs BLOZF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, BLOZF has a market cap of 49.41M. Regarding current trading prices, SSII is priced at $8.91, while BLOZF trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas BLOZF's P/E ratio is -21.45. In terms of profitability, SSII's ROE is -1.33%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, SSII is more volatile compared to BLOZF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs IPDQF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, IPDQF has a market cap of 40.55M. Regarding current trading prices, SSII is priced at $8.91, while IPDQF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas IPDQF's P/E ratio is -2.00. In terms of profitability, SSII's ROE is -1.33%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, SSII is more volatile compared to IPDQF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs NVYTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, SSII is priced at $8.91, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas NVYTF's P/E ratio is -0.74. In terms of profitability, SSII's ROE is -1.33%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, SSII is more volatile compared to NVYTF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs TLTFF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, TLTFF has a market cap of 30.35M. Regarding current trading prices, SSII is priced at $8.91, while TLTFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas TLTFF's P/E ratio is -12.25. In terms of profitability, SSII's ROE is -1.33%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, SSII is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs ELXMF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, SSII is priced at $8.91, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, SSII's ROE is -1.33%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, SSII is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs PYNKF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, PYNKF has a market cap of 27.75M. Regarding current trading prices, SSII is priced at $8.91, while PYNKF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas PYNKF's P/E ratio is -1.65. In terms of profitability, SSII's ROE is -1.33%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, SSII is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs KBBTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, SSII is priced at $8.91, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, SSII's ROE is -1.33%, compared to KBBTF's ROE of N/A. Regarding short-term risk, SSII is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs EMITF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, SSII is priced at $8.91, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas EMITF's P/E ratio is -15.38. In terms of profitability, SSII's ROE is -1.33%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, SSII is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs POSC Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, POSC has a market cap of 22.13M. Regarding current trading prices, SSII is priced at $8.91, while POSC trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas POSC's P/E ratio is 0.39. In terms of profitability, SSII's ROE is -1.33%, compared to POSC's ROE of +9.25%. Regarding short-term risk, SSII is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs ASAPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ASAPF has a market cap of 16.91M. Regarding current trading prices, SSII is priced at $8.91, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ASAPF's P/E ratio is -21.90. In terms of profitability, SSII's ROE is -1.33%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, SSII is more volatile compared to ASAPF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs MDXHF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MDXHF has a market cap of 15.40M. Regarding current trading prices, SSII is priced at $8.91, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, SSII's ROE is -1.33%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, SSII is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs VPTDF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, VPTDF has a market cap of 14.46M. Regarding current trading prices, SSII is priced at $8.91, while VPTDF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas VPTDF's P/E ratio is -4.43. In terms of profitability, SSII's ROE is -1.33%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, SSII is more volatile compared to VPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs TMDIF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, SSII is priced at $8.91, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, SSII's ROE is -1.33%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, SSII is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs DIZTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, SSII is priced at $8.91, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, SSII's ROE is -1.33%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, SSII is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs PLLWF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, SSII is priced at $8.91, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, SSII's ROE is -1.33%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, SSII is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs RMSL Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, RMSL has a market cap of 12.74M. Regarding current trading prices, SSII is priced at $8.91, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas RMSL's P/E ratio is 0.83. In terms of profitability, SSII's ROE is -1.33%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, SSII is more volatile compared to RMSL. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs ATBPF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, SSII is priced at $8.91, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, SSII's ROE is -1.33%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, SSII is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs LXXGF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, SSII is priced at $8.91, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, SSII's ROE is -1.33%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, SSII is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs GTHP Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, GTHP has a market cap of 9.86M. Regarding current trading prices, SSII is priced at $8.91, while GTHP trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas GTHP's P/E ratio is -2.50. In terms of profitability, SSII's ROE is -1.33%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, SSII is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs IRME Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, IRME has a market cap of 8.64M. Regarding current trading prices, SSII is priced at $8.91, while IRME trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas IRME's P/E ratio is -4.00. In terms of profitability, SSII's ROE is -1.33%, compared to IRME's ROE of +11.77%. Regarding short-term risk, SSII is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs MKEAF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MKEAF has a market cap of 6.43M. Regarding current trading prices, SSII is priced at $8.91, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, SSII's ROE is -1.33%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, SSII is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs DTXMF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, SSII is priced at $8.91, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, SSII's ROE is -1.33%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, SSII is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs TBRIF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, TBRIF has a market cap of 5.45M. Regarding current trading prices, SSII is priced at $8.91, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas TBRIF's P/E ratio is -1.20. In terms of profitability, SSII's ROE is -1.33%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, SSII is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs QLIS Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, SSII is priced at $8.91, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas QLIS's P/E ratio is 2.22. In terms of profitability, SSII's ROE is -1.33%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, SSII is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs RHNMF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, SSII is priced at $8.91, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, SSII's ROE is -1.33%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, SSII is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs MICR Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, SSII is priced at $8.91, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas MICR's P/E ratio is -3.47. In terms of profitability, SSII's ROE is -1.33%, compared to MICR's ROE of -0.25%. Regarding short-term risk, SSII is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs FZMD Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, FZMD has a market cap of 4.43M. Regarding current trading prices, SSII is priced at $8.91, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas FZMD's P/E ratio is 1.20. In terms of profitability, SSII's ROE is -1.33%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, SSII is less volatile compared to FZMD. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs NUMD Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, NUMD has a market cap of 4.34M. Regarding current trading prices, SSII is priced at $8.91, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas NUMD's P/E ratio is 5.20. In terms of profitability, SSII's ROE is -1.33%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, SSII is more volatile compared to NUMD. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs LBLTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, SSII is priced at $8.91, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, SSII's ROE is -1.33%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, SSII is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs ADMT Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ADMT has a market cap of 4.06M. Regarding current trading prices, SSII is priced at $8.91, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ADMT's P/E ratio is -6.00. In terms of profitability, SSII's ROE is -1.33%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, SSII is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs VYCO Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, VYCO has a market cap of 4.00M. Regarding current trading prices, SSII is priced at $8.91, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas VYCO's P/E ratio is -12.00. In terms of profitability, SSII's ROE is -1.33%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, SSII is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs ALRTF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ALRTF has a market cap of 3.81M. Regarding current trading prices, SSII is priced at $8.91, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ALRTF's P/E ratio is -0.20. In terms of profitability, SSII's ROE is -1.33%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, SSII is more volatile compared to ALRTF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs BIEL Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, SSII is priced at $8.91, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas BIEL's P/E ratio is N/A. In terms of profitability, SSII's ROE is -1.33%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, SSII is more volatile compared to BIEL. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs VANIW Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, SSII is priced at $8.91, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas VANIW's P/E ratio is N/A. In terms of profitability, SSII's ROE is -1.33%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, SSII is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs ESMC Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, ESMC has a market cap of 3.09M. Regarding current trading prices, SSII is priced at $8.91, while ESMC trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas ESMC's P/E ratio is 8.34. In terms of profitability, SSII's ROE is -1.33%, compared to ESMC's ROE of +0.47%. Regarding short-term risk, SSII is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs PMEDF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, PMEDF has a market cap of 3.01M. Regarding current trading prices, SSII is priced at $8.91, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas PMEDF's P/E ratio is -2.00. In terms of profitability, SSII's ROE is -1.33%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, SSII is more volatile compared to PMEDF. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs USAQ Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, USAQ has a market cap of 2.99M. Regarding current trading prices, SSII is priced at $8.91, while USAQ trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas USAQ's P/E ratio is -6.62. In terms of profitability, SSII's ROE is -1.33%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, SSII is more volatile compared to USAQ. This indicates potentially higher risk in terms of short-term price fluctuations for SSII.
SSII vs KLYG Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, KLYG has a market cap of 2.02M. Regarding current trading prices, SSII is priced at $8.91, while KLYG trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas KLYG's P/E ratio is -16.00. In terms of profitability, SSII's ROE is -1.33%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, SSII is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.
SSII vs CRRVF Comparison
SSII plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SSII stands at 1.73B. In comparison, CRRVF has a market cap of 1.54M. Regarding current trading prices, SSII is priced at $8.91, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SSII currently has a P/E ratio of -111.37, whereas CRRVF's P/E ratio is N/A. In terms of profitability, SSII's ROE is -1.33%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, SSII is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for SSII.